Cure My Disease

Don't miss your cure!

 Log in / Sign up

Home blood pressure monitoring: which delivery and training method works best?

NCT ID NCT07693699

Disease control Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Aug 13, 2026 · Updated 5 times

Summary

This study compares different ways to give blood pressure cuffs and training to adults with uncontrolled high blood pressure during routine primary care visits. Participants receive a cuff either in the clinic or by mail, and training either hands-on or through written instructions. The goal is to find which approach most reliably gets people the tools and knowledge they need to monitor their blood pressure at home.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could identify the most practical and effective way to help people with high blood pressure monitor their condition at home, potentially improving blood pressure control.
What could go wrong
This is a small, pragmatic study focused on delivery and training methods, not on direct health outcomes. Results may not apply to all clinics or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. * Diagnosed hypertension documented prior to the index clinic visit. * Scheduled for and attends an in-person visit with a participating clinician at a study clinic. * Elevated BP (blood pressure) documented in Epic during rooming or the clinic visit before study enrollment, defined as systolic BP \>=140 mmHg or diastolic BP \>=90 mmHg. Exclusion Criteria: * Visit is canceled, rescheduled, or the patient does not attend the visit. * Patient already has a usable home BP cuff provide through insurance within the past 5 years. * Patient declines assistance obtaining a BP cuff. * Patient declines submitting cuff order to insurance. * Patient unable to participate for operational reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypertension

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Advocate Medical Group Beverly

    RECRUITING

    Chicago, Illinois, 60643, United States

  • Advocate Medical Group Chicago (Imani Village)

    RECRUITING

    Chicago, Illinois, 60619, United States

  • Advocate Medical Group Chicago (Southeast)

    RECRUITING

    Chicago, Illinois, 60617, United States

  • Advocate Medical Group Merrionette Park

    RECRUITING

    Merrionette Park, Illinois, 60803, United States

  • Advocate Medical Group Oak Lawn (FP)

    RECRUITING

    Oak Lawn, Illinois, 60453, United States

  • Advocate Medical Group Oak Lawn (IM)

    RECRUITING

    Oak Lawn, Illinois, 60453, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.